ArticleNature medicine2013

Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.

Gannie Tzoneva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.